LEADER 02924cam a2200361Ii 4500
001 802245
003 TR_AnAIT
005 20260123023659
008 180706s2018 enka o 000 0 eng d
020 |a9781315136103|q(e-book : PDF)
020 |a9781351470582|q(e-book: Mobi)
020 |z9781138103146|q(hardback)
024 7 |a10.4324/9781315136103 |2doi
035 |a(OCoLC)1005188780
040 |aFlBoTFG|cFlBoTFG|erda
041 |aeng
043 |aa-ii---
049 |aTürk Tarih Kurumu Kütüphanesi
050 4|aRA401.I4|bP65 2018
082 04|a362.17820954|bP769
245 04|aThe Politics of the Pharmaceutical Industry and Access to Medicines :|bWorld Pharmacy and India /|c[edited by Hans LÖfgren].
250 |aFirst edition.
264 1|aLondon :|bRoutledge,|c2018.
300 |a1 online resource (xx, 370 pages)
336 |atext|2rdacontent
337 |acomputer|2rdamedia
338 |aonline resource|2rdacarrier
505 00|tchapter 1 The Pharmaceutical Industry and Access to Medicines in India -- |tchapter 2 Challenges of Regulation of Medicines in India /|rS. Srinivasan -- |tchapter 3 CIPLA: Patients before Patents /|rNeelam Raaj -- |tchapter 4 Systemic Failure of Regulation: The Political Economy of Pharmaceutical and Bulk Drug Manufacturing -- |tchapter 5 TRIPS Flexibilities and Access to Patented Medicines in India -- |tchapter 6 India’s Free Trade Agreements: Implications for Access to Medicines in India and the Global South -- |tchapter 7 At any Price? Boehringer Ingelheim, Bayer HealthCare and Baxter in India -- |tchapter 8 Trends and Prospects for India as a Global Generic Player /|rPlayer Deepak Kumar Jena -- |tchapter 9 The Indian Patent Law and Access to Antiretroviral Drugs in Sub-Saharan Africa -- |tchapter 10 Accessing Medicines in Developing Economies /|rTu Thanh Nguyen -- |tchapter 11 The Politics of AIDS Treatment in Brazil /|rAndré de Mello e Souza -- |tchapter 12 Financing Pharmaceutical Research and Development: Alternatives to the Patent System -- |tchapter 13 Post-script /|rHans Löfgren.
520 |a"The book studies the pharmaceutical industry of India. It is one of the most successful stories of economic expansion and improvements in public health. Indian firms have made access to quality medicines possible and affordable in many developing countries. Indian pharmaceuticals are also exported on a large scale to the United States and other highly regulated markets. A wave of mergers, acquisitions and tie-ups point to growing integration between Indian firms and global pharma multinationals."--Provided by publisher.
650 0|aPharmaceutical policy|zIndia.
650 0|aPharmacy|xLaw and legislation|zIndia.
650 0|aPharmacy|xLaw and legislation.
650 0|aDrug accessibility|xLaw and legislation|zIndia.
650 0|aDrug accessibility.
700 1 |aLÖfgren, Hans,|eeditor.
776 08|iPrint version: |z9781138103146
856 40|uhttps://www.taylorfrancis.com/books/9781315136103|zClick here to view.
901 |aTaylor & Francis